September 17, 2012
Speaker: Phyllis Arthur, Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy, Biotechnology Industry Organization
The timely availability of medical countermeasures-drugs, vaccines and other medical resources needed for a robust response-is a key component of US biosecurity. Ms. Arthur discusses the role of public-private partnerships in drug and vaccine development and production and broadly outlines the roles that Congress, the Administration, and the private sector play regarding US biodefense policy.
As a senior leader at the Biotechnology Industry Organization (BIO), Ms. Arthur has a unique and critical role at the interface between the resources and requirements of the US government and the research, development, manufacturing, and production capabilities of private industry.
Our Mission
To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.
Copyright © Johns Hopkins University | Terms of Use and Privacy Policy | Site map | Site search